Social Responsibility

Breast cancer survey shows allied health gap

Health Industry Hub | October 9, 2019 |
[Total: 1    Average: 5/5]

Breast cancer survivors affected by the financial cost of allied health have revealed the need for urgent improvement in the delivery of specialist health services.

The issue was revealed in a survey conducted by Breast Cancer Network Australia (BCNA), which has called for more funding for allied health outpatient services in public hospitals, and an increase of the Medicare rebate for allied health from five visits per year to 10.

Long-term treatment side effects such as lymphoedema management, sexual dysfunction, anxiety and depression, require ongoing and regular visits to allied health specialists.

BCNA CEO Kirsten Pilatti said these specialists were are an essential, yet often unfunded component of follow-up care.

‘There are so many studies highlighting the importance of specialists such as exercise physiologists for a breast cancer treatment plan.

‘For many breast cancer survivors, the cost of accessing the expertise of these specialists puts them beyond their reach. We want a system that helps women and men diagnosed with breast cancer to come out and be able to move on with their life, not be crushed by the experience.’

The 2018 survey, which involved more than 10,000 men and women, formed part of BCNA’s State of the Nation report. It revealed around one third needed information about allied health-related services to help them manage treatment side effects.

Asked about their needs which would be included under an allied health care plan, 35 per cent listed lymphoedema, 32.5 per cent nutrition and exercise physiology and 20 per cent needed support for sexual wellbeing.  

Kirsten said the research pointed to a range of gaps meeting the financial, emotional and practical needs of people diagnosed with breast cancer.

BCNA’s network from around the country highlighted the cost of accessing allied health services as a major concern.

‘The number of sessions covered under Medicare aren’t enough to cope with my need to see a lymphoedema specialist, but I can’t afford any further sessions,’ said Keira Bale from Newcastle.

‘Cost was clearly the major issue with my allied health plan,’ said Mossman survivor Kim Parish. ‘It impacted the number of visits with my psychologist and meant I had to build in more time between visits just to cover the added expense.’

Kirsten said improved access to allied health was critical for breast cancer survivors.

‘The people who do have a Chronic Disease Management Plan (CDMP) highlighted the inadequacies of Medicare rebates restricting allied health plans to just five visits per year. Some newly diagnosed people use up that number in their first month.

‘Some are not even advised by their doctor of the availability of a CDMP. They are forced to cover the total cost to access the allied health services they require.’

BCNA’s research shows the average out-of-pocket expenses for breast cancer survivors was $5,000 in the first five years after diagnosis. One quarter reported costs of more than $17,200.

‘That does not factor in reduced earning capacity through lost wages or the additional costs of people living in regional and rural areas faced due to travel and accommodation.

‘Once people move into the survivorship phase, these services become even more difficult to access or find, and don’t always appear in follow-up care plans.’

‘To make a real impact we need a coordinated approach. BCNA is urging the government to increase the allied health plan, health professionals to refer their patients to programs and services and patients to be proactive about their own health.’

You may also like New report reveals two thirds of people think dementia is a normal part of ageing, rather than a medical condition

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - Pharma industry pledges to continue 20 year partnership with Gavi, the Vaccine Alliance

Pharma industry pledges to continue 20 year partnership with Gavi, the Vaccine Alliance

Health Industry Hub | June 5, 2020 |

The world’s leading biopharmaceutical and vaccines companies restate their commitment to supporting the Vaccine Alliance Gavi‘s mission to protect future […]


Leadership & Management

Leadership Management Qualities - Resuming face to face interactions with healthcare professionals post COVID-19

Resuming face to face interactions with healthcare professionals post COVID-19

Health Industry Hub | June 4, 2020 |

As countries lift lockdown restrictions, the international pharma industry body, IFPMA, provides its members with ethical considerations on when and how to […]


News & Trends - Medical Technology

MedTech News - Varian's AI machine personalises cancer therapy and halves treatment time

Varian’s AI machine personalises cancer therapy and halves treatment time

Health Industry Hub | June 3, 2020 |

MedTech News: A Sydney patient is the first Australian in the Southern Hemisphere to receive revolutionary new personalised cancer therapy […]


News & Trends - Pharmaceuticals

Pharma News - ASCO highlights - Janssen, Takeda, AZ, Genentech, MSD, BMS and Noxopharm

ASCO highlights – Janssen, Takeda, AZ, Genentech, MSD, BMS and Noxopharm

Health Industry Hub | June 3, 2020 |

Pharma News: The American Society of Clinical Oncology (ASCO) 2020 meeting was held virtually this year due to the COVID-19 […]